+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Candesartan"

From
Unisia (Amlodipine + Candesartan) - API Insight, 2022 - Product Thumbnail Image

Unisia (Amlodipine + Candesartan) - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Unisia (Amlodipine + Candesartan)- Drug Insight, 2019 - Product Thumbnail Image

Unisia (Amlodipine + Candesartan)- Drug Insight, 2019

  • Report
  • January 2019
  • 35 Pages
  • Global
From
Global and Chinese Candesartan Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Candesartan Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 148 Pages
  • Global, China
From
From
From
From
Hypertension Drugs Markets in China - Product Thumbnail Image

Hypertension Drugs Markets in China

  • Report
  • November 2023
  • 215 Pages
  • China
From
Hypertension Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Hypertension Drugs Industry Forecasts - China Focus

  • Report
  • November 2023
  • 109 Pages
  • China
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Candesartan is a drug used to treat hypertension and congestive heart failure. It is a type of angiotensin II receptor antagonist, which works by blocking the action of a hormone that causes blood vessels to narrow. This helps to reduce blood pressure and improve the heart's ability to pump blood. Candesartan is also used to reduce the risk of stroke in people with high blood pressure and left ventricular hypertrophy. Candesartan is available in both generic and branded forms. It is marketed by several pharmaceutical companies, including Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. It is also available in combination with other drugs, such as hydrochlorothiazide and amlodipine. In the cardiovascular drugs market, Candesartan is a popular choice for treating hypertension and congestive heart failure. It is well-tolerated and has a low risk of side effects. It is also cost-effective, making it an attractive option for many patients. Companies in the Candesartan market include Novartis, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more